Community pharmacy owners are being asked to share their views a following the new CPCF funding settlement, ahead of the next full Community Pharmacy England Committee meeting taking place at the end of this month (30th April to 1st May). The new CPCF arrangements mark a pivotal moment for the sector and while the Committee
Read moreIn discussions with DHSC, Community Pharmacy England has agreed a mechanism to allow pharmacy owners to receive the 19p Single Activity Fee (SAF) increase sooner for dispensing months of April 2025 and May 2025. The advanced payments for these dispensing months will be adjusted to incorporate the uplift to the SAF. No adjustment to advance
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Fentanyl (Durogesic® DTrans®) 12micrograms/hour, 25micrograms/hour, 50micrograms/hour, 75micrograms/hour, and 100micrograms/hour patches. MSN/2025/023 Tier 2 – medium impact Date of issue: 15th April 2025 Durogesic® DTrans® 75micrograms/hour patches are out of stock until December 2025. Durogesic® DTrans® 12micrograms/hour patches will be out of
Read moreThe GPhC has jointly issued an enforcement notice with the ASA and MHRA, which makes it clear that adverts for named prescription-only medicines (POMs) for weight management are prohibited. The GPhC will write to pharmacists, pharmacy technicians, and pharmacy owners to raise awareness of this enforcement notice. The post GPhC joint Enforcement Notice: Prescription-only
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Galantamine 8mg, 16mg and 24mg modified-release capsules. MSN/2025/022 Tier 2 – medium impact Date of issue: 11th April 2025 Galantamine 8mg modified release capsules are in limited supply until late July 2025. Galantamine 16mg modified release capsules will be out of
Read moreCommunity Pharmacy England CEO Janet Morrison and Steve Race MP, Chair of the APPG for Pharmacy, hosted a Parliamentary event this week (Monday 7th April) on the pharmacy funding settlement for 2024/25 and 2025/26. Community Pharmacy England representatives met with 25 cross-party MPs and Parliamentary Staff Members at the Houses of Parliament, with some dialing
Read moreA recorded presentation on the new funding and contractual arrangements for community pharmacies is now available to watch on-demand. Following the announcement of the Community Pharmacy Contractual Framework (CPCF) settlement last week, Community Pharmacy England has been working around the clock to provide information, develop resources and answer your questions. Part of this work included
Read moreMHRA Class 2 Medicines Notification: Synalar GEL 30g, Synalar GEL 60g,(fluocinoline acetonide 0.025%) Reig Jofre UK Drug alert number: EL(25)A/16 Date issued: 08 April 2025 It has been identified that the batches of Synalar Gel 30g and 60g listed in this notification contain a residual solvent (benzene) at a level exceeding the ICH limit of
Read moreMHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) Date issued: 7 April 2025 Cross Healthcare Limited has informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension. DMRC reference number: DMRC-35184448 Company name:
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Diltiazem (Angitil® SR) 90mg modified-release capsules. MSN/2025/020 Tier 2 – medium impact Date of issue: 7th April 2025 Diltiazem (Angitil® SR) 90mg modified-release capsules are out of stock until w/c 28 April 2025. Diltiazem (Tildiem Retard®) 90mg prolonged-release tablets remain available
Read more
